BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36388433)

  • 41. Identification of the HECT E3 ligase UBR5 as a regulator of MYC degradation using a CRISPR/Cas9 screen.
    Schukur L; Zimmermann T; Niewoehner O; Kerr G; Gleim S; Bauer-Probst B; Knapp B; Galli GG; Liang X; Mendiola A; Reece-Hoyes J; Rapti M; Barbosa I; Reschke M; Radimerski T; Thoma CR
    Sci Rep; 2020 Nov; 10(1):20044. PubMed ID: 33208877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
    Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
    Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
    [No Abstract]   [Full Text] [Related]  

  • 43. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples.
    Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C
    Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic Association Analysis of Cell Cycle Regulators Reveals
    Yu CC; Chen LC; Lin WH; Lin VC; Huang CY; Lu TL; Lee CH; Huang SP; Bao BY
    Cancer Genomics Proteomics; 2020; 17(2):209-216. PubMed ID: 32108043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. KDF1 Promoted Proliferation and Metastasis of Epithelial Ovarian Cancer
    Zhu C; Liu Y; Tong R; Guan J
    Front Genet; 2022; 13():808100. PubMed ID: 35281796
    [No Abstract]   [Full Text] [Related]  

  • 47. The MLLE domain of the ubiquitin ligase UBR5 binds to its catalytic domain to regulate substrate binding.
    Muñoz-Escobar J; Matta-Camacho E; Kozlov G; Gehring K
    J Biol Chem; 2015 Sep; 290(37):22841-50. PubMed ID: 26224628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circular RNA Paired-Related Homeobox 1 Promotes Gastric Carcinoma Cell Progression via Regulating MicroRNA-665/YWHAZ Axis.
    Liu W; Hu W; Hou K; Zhu S
    Dig Dis Sci; 2021 Nov; 66(11):3842-3853. PubMed ID: 33201331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A review: targeting UBR5 domains to mediate emerging roles and mechanisms: chance or necessity?
    Wang Y; Niu K; Shi Y; Zhou F; Li X; Li Y; Chen T; Zhang Y
    Int J Surg; 2024 May; ():. PubMed ID: 38701508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prognostic model for hepatocellular carcinoma based on apoptosis-related genes.
    Liu R; Wang G; Zhang C; Bai D
    World J Surg Oncol; 2021 Mar; 19(1):70. PubMed ID: 33712023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. YWHAZ promotes ovarian cancer metastasis by modulating glycolysis.
    Shi J; Ye J; Fei H; Jiang SH; Wu ZY; Chen YP; Zhang LW; Yang XM
    Oncol Rep; 2019 Feb; 41(2):1101-1112. PubMed ID: 30535456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
    Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F
    Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The E3 ubiquitin ligase UBR5 regulates centriolar satellite stability and primary cilia.
    Shearer RF; Frikstad KM; McKenna J; McCloy RA; Deng N; Burgess A; Stokke T; Patzke S; Saunders DN
    Mol Biol Cell; 2018 Jul; 29(13):1542-1554. PubMed ID: 29742019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer.
    Shearer RF; Iconomou M; Watts CK; Saunders DN
    Mol Cancer Res; 2015 Dec; 13(12):1523-32. PubMed ID: 26464214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
    Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
    World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BoxCar and shotgun proteomic analyses reveal molecular networks regulated by UBR5 in prostate cancer.
    Yan Y; Zhou B; Lee YJ; You S; Freeman MR; Yang W
    Proteomics; 2022 Feb; 22(4):e2100172. PubMed ID: 34897998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic significance of YWHAZ expression in localized prostate cancer.
    Rüenauver K; Menon R; Svensson MA; Carlsson J; Vogel W; Andrén O; Nowak M; Perner S
    Prostate Cancer Prostatic Dis; 2014 Dec; 17(4):310-4. PubMed ID: 25156059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer.
    Yang Q; Yu B; Sun J
    Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma.
    Nishimura Y; Komatsu S; Ichikawa D; Nagata H; Hirajima S; Takeshita H; Kawaguchi T; Arita T; Konishi H; Kashimoto K; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Br J Cancer; 2013 Apr; 108(6):1324-31. PubMed ID: 23422756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.